Avalo Therapeutics, Inc. (AVTX) 13D/13G Filings for Aytu BioPharma, Inc. (AYTU)

Avalo Therapeutics, Inc. 13D and 13G filings for Aytu BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2020-04-27
4:30 pm
Unchanged		2020-04-1013GAytu BioPharma, Inc.
AYTU		Avalo Therapeutics Inc.
AVTX		0
0.000%		0
(Unchanged)		Filing